miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8+ T cell fate
暂无分享，去创建一个
W. Telford | Wei Zhu | Thelma M. Escobar | S. Dell’Orso | S. Muljo | James D. Hocker | L. Di Croce | V. Sartorelli | L. Gattinoni | V. Kapoor | Yi Zhang | Shan He | Jinhui Hu | S. Gautam | Xia Yang | Tuoqi Wu | J. Fioravanti | N. Hawk | Yun Ji | John B. Le Gall | Neal E. Lacey | Hongjun Wang